Cellectar Biosciences, Inc. Cash and Restricted Cash
Cellectar Biosciences, Inc. (CLRB) had Cash and Restricted Cash of $33.99 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.99M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.35M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.20M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.55M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $33.99M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $8.35M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $13.20M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $12.55M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.04M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $13.91M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $23.29M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $34.26M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $25.87M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $40.03M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $9.56M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $18.99M 10-Q · filed 2024-11-18 | |
| 2023-06-30 | $5.15M 10-K/A · filed 2024-10-29 | |
| 2023-03-31 | $12.68M 10-K/A · filed 2024-10-29 | |
| 2022-12-31 | $19.87M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $17.79M 10-K/A · filed 2024-10-29 | |
| 2022-06-30 | $24.81M 10-K/A · filed 2024-10-29 | |
| 2022-03-31 | $30.63M 10-K/A · filed 2024-10-29 | |
| 2021-12-31 | $35.70M 10-K/A · filed 2024-10-29 | |
| 2021-09-30 | $40.34M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $46.78M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $53.63M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $57.17M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $18.84M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $22.45M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $7.09M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $10.61M 10-K · filed 2022-03-21 | |
| 2019-09-30 | $13.30M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $16.85M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $10.49M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $13.31M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $16.43M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $4.24M 10-Q · filed 2019-08-12 | |
| 2018-03-31 | $6.88M 10-Q · filed 2019-05-06 | |
| 2017-12-31 | $10.06M 10-K · filed 2020-03-09 | |
| 2017-09-30 | $5.72M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $8.37M 10-Q · filed 2018-08-10 | |
| 2017-03-31 | $11.24M 10-Q · filed 2018-05-11 | |
| 2016-12-31 | $11.50M 10-K · filed 2019-02-26 | $11.44M 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |